Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme
Abstract Background The Compassionate Access Scheme (CAS) being delivered through the Queensland Children's Hospital is designed to allow access to an investigational purified Cannabidiol oral solution to paediatric patients with severe refractory epilepsy. The objectives of this study were to...
Saved in:
Main Authors: | S. Harte (Author), Y. Singh (Author), S. Malone (Author), H. Heussler (Author), G. Wallace (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
by: Umberto Raucci, et al.
Published: (2020) -
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
by: Claudia Taborda Gómez, et al.
Published: (2021) -
∆9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
by: José Alexandre Crippa, et al.
Published: (2016) -
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
by: Manuela Contin, et al.
Published: (2021) -
Epilepsy and cannabidiol - a new perspective for seizures treatment
by: Ilona Kozioł, et al.
Published: (2021)